Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

PepMix Collection Cynomolgus CMV (25 ug/peptide/vial

PepMix Collection Cynomolgus CMV (25 ug/peptide/vial) US$1,375.40 Excluding tax and shipping fees Limited stock Description About PepMix Collection Cynomolgus CMV (25 ug/peptide/vial) Collection of 3 peptide pools (overlapping peptides scans, 15mers with 11 aa

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

US$1,375.40

Excluding tax and shipping fees

Limited stock

Description

About PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

Collection of 3 peptide pools (overlapping peptides scans, 15mers with 11 aa overlap) through 3 immunodominant antigens of Cynomolgus macaque cytomegalovirus (CyCMV): PM-cyCMVX (selected epitopes); PM-cyCMV-UL55 (15mers with 11aa overlap); PM-cyCMV-UL83 (15mers with 11aa overlap).

PepMix Collection Cynomolgus CMV (25 ug/peptide/vial) - Specifications

Amount: 25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)

Purity: Development Grade: each peptide purified to > 70% (HPLC/MS) - (equivalent to an average purity of 85%)

Delivery Format: Freeze-dried in 3 glass vials

Application(s): T-cell immunity

Condition(s)/Topic(s): Infection, Infectious mononucleosis

Standard Delivery Time: 2-5 days

Visit our webpage for more information on Peptide Tools to Study CMV

Are you interested in your own custom PepMix? Choose your sequence, amount, purity and pool format. We will assist you along the way. Custom PepMix Peptide Pools.

PepMix™ Peptide PoolsProtein-spanning mixtures of overlapping peptides (PepMix™) are extremely efficient for- Antigen-specific T cell stimulation in T cell assays (e.g. in ELISpot, ICS, cell-mediated cytotoxicity or proliferation assays)- In-vitro T cell expansion- Dendritic cell pulsing- Immune monitoring- Cellular immune response profiling- T cell epitope identification- Standardization of T cell assays

Benefits of PepMix™- Each peptide quality controlled and guaranteed for identity and purity- CoA and HPLC-MS data available- High batch-to-batch consistency- No false positive T cell responses by contaminating deletion peptides- No toxic inhibition of T cell responses due to stringent purification of each peptide- Minimization of endotoxin contamination due to low bioburden process- ADCF policy in place- HLA independent stimulation (with antigen spanning peptide pools)

References

References for PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

ReferencesRead References with PepMix™ Peptide Pools for Infectious Diseases COVID-19 related PepMixes™ PepMix™ Control Pools

Application NotesCross-reactive T cells enhance immune responses in SARS-CoV-2 infection and vaccinationLoyal et al (2021) Full textPeptide Tools to Support the Fight against COVID-19Alem et al (2020) Full textCEFX/EFX Ultra SuperStim Pools: Superior positive controls for T-cell assays with broad MHC-allele and antigen coverageEckey et al. (2017) Full textDeveloping Multi-HIV Antigen Specific T-Cells as a Component of a Cure StrategyLam et al. (2015) Full textPeptide-stimulated Expansion of Virus-specific T cells For Preventative Treatment After Allogeneic Stem Cell TransplantationGary et al. (2015) Full textPepMix™ Peptide Pools for Clinical Applications: T Cell Therapy for Viral Infections after Hematopoietic Stem Cell TransplantKeirnan et al. (2012) Full textCytomegalovirus Protein Spanning PepMix™ Peptide Pools to Discover Changes in T-Cell Immunity in the Aging PopulationKern (2012) Full text

Documentation

Documentation for PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

Protocol_PepMix.pdf

PM-CyCMV-UL55.pdf

PM-CyCMV-UL83.pdf

Properties

Properties of PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

25 µg (approx. 15 nmol) / peptide (for stimulation of up to 2,5 x 108 cells)

T-cell immunity

PepMix Collections, PepMix Peptide Pools

Infection, Infectious mononucleosis

Freeze-dried in 3 glass vials

Cynomolgus macaque cytomegalovirus (CyCMV)

Selected proteins

Development Grade: each peptide purified to > 70% (HPLC/MS)

No

Further Information to PepMix Collection Cynomolgus CMV (25 ug/peptide/vial)

Values

Collection of 3 vials of Cynomolgus macaque cytomegalovirus (CyCMV) peptide pools: PM-cyCMVX (selected epitopes) PM-cyCMV-UL55 (15mers with 11aa overlap) PM-cyCMV-UL83 (15mers with 11aa overlap) Copy Sequence Show complete Sequence Show trimmed Sequence

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

What "Research Use Only" Actually Means on a Peptide Vial

What "Research Use Only" Actually Means — and Why It's on Every Vial "Research Use Only" isn't marketing boilerplate — it's a specific regulatory category with real meaning. Here's what RUO labeling does and doesn't say. Research-use-only context. This article explains the regulatory and labeling meaning of "Research Use Only." It is not legal advice, not medical advice, and not a usage guide. American Peptides products are sold strictly for in vitro laboratory research and are not for human or veterinary use. Three words appear on every credible research-peptide vial: Research Use Only. To a lot of buyers it reads like a legal shrug — boilerplate a lawyer insisted on. It isn't. "Research Use Only" (RUO) is a specific labeling category with concrete meaning for how a product was made, how it can be sold, and how it should be handled. Understanding it is part of being a competent purchaser. RUO is a category, not a disclaimer In the United States, products intended for laboratory research are distinct from drugs, dietary supplements, medical devices, and in vitro diagnostic (IVD) products. Each of those categories carries its own regulatory framework, manufacturing expectations, and approval pathway. RUO products sit deliberately outside the drug and IVD frameworks: they are intended for laboratory experimentation and are not evaluated for safety or effectiveness in humans or animals. That placement is the entire point. An RUO label is an affirmative statement of intended use — "this material is for the research bench" — not merely a wish that nobody misuse it. What RUO does say Intended use is laboratory research. In vitro experiments, cell culture, analytical method development, reference standards, and similar bench contexts. The product is not an approved drug. It has not gone through the clinical evaluation and approval process required for human therapeutic products. It is not a diagnostic. Results generated with it are not validated for clinical decision-making. Manufacturing is to research specifications. Quality is typically demonstrated through analytical Certificates of Analysis (purity, identity, and often sterility/endotoxin), not through pharmaceutical GMP drug approval unless a supplier explicitly states otherwise. What RUO does NOT say RUO labeling is not a quality grade by itself. Two RUO peptides can differ enormously in purity, identity verification, and contaminant screening. RUO tells you the regulatory lane; the COA tells you the quality. Don't conflate the two — a vial can be correctly labeled RUO and still be poorly characterized material. The label is necessary, not sufficient. RUO also does not mean "unregulated." Suppliers still operate under consumer-protection law, truth-in-advertising rules, controlled-substance law where applicable, and shipping and customs regulation. The RUO category constrains how a product may be marketed: a compliant supplier will not attach human dosing, administration instructions, or therapeutic benefit claims to an RUO product, because doing so reclassifies the marketing into territory the product was never evaluated for. Why it's on every vial The label travels with the material because intended use is established at the point of sale and labeling. A clear RUO statement on the vial, the COA, the invoice, and the website does three things at once: It sets the legal lane. It documents that the product was sold for research, not as a therapeutic. It informs the researcher. It signals that safety/efficacy data for human or animal use does not exist for this material and should not be assumed. It disciplines the marketing. A supplier that takes RUO seriously will keep all surrounding content — product pages, blog posts, support replies — within research-and-chemistry framing. How RUO shapes good purchasing behavior If you're sourcing for a lab, RUO labeling should change what you ask a vendor for. Instead of efficacy or outcome information (which an RUO product has none of), ask for the analytical record: A batch-specific, third-party COA with HPLC purity and mass spec identity Endotoxin and sterility data where the application is contamination-sensitive Storage and transit conditions appropriate to a lyophilized research compound Clear, research-framed product documentation with no human-use language A vendor that responds to those questions with substantive analytical answers is operating in the RUO lane correctly. A vendor that pivots to benefit claims or usage protocols is signaling that they don't — and that should weigh on your sourcing decision as heavily as any purity number. The bottom line "Research Use Only" is the regulatory address of the product. It tells you the material lives on the research bench, was characterized analytically rather than clinically, and must be evaluated on its COA rather than on outcome claims that, by definition, do not exist for an RUO compound. The label is small. What it communicates is not. Does "Research Use Only" mean the product is low quality? No. RUO is a regulatory and intended-use category, not a quality grade. Quality is established by the Certificate of Analysis — purity, identity, and contaminant testing — independent of the RUO label. Why can't an RUO supplier publish dosing or benefit information? Because RUO products are not evaluated for safety or effectiveness in humans or animals. Attaching dosing or therapeutic claims to them misrepresents the regulatory category the product was sold under. Is RUO the same as "not regulated"? No. RUO products still fall under consumer-protection, advertising, shipping, customs, and (where applicable) controlled-substance law. RUO defines the intended-use lane, not an absence of oversight. To see how American Peptides documents the RUO lane in practice, browse our published COA library or explore the research peptide catalog. This article is for laboratory research reference only. American Peptides products are sold strictly for in vitro research. Not for human consumption.

Source: americanpeptides.us ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →